At a glance
ClinicalIndex Comparison RecordN/ACompleted· 615 enrolled
Drug / intervention
25G FNA needle +1 moredevice
Likely dose
25G FNA needlefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter Randomized Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device
In Brief
A clinical study evaluating 25G FNA needle and 20G ProCore FNB needle for Pancreatic Masses and Lymph Nodes. Completed, enrolled 615 participants across 13 sites in 10 countries.
Detailed Summary
The aim of this study is to compare the diagnostic accuracy of two EUS-guided tissue acquisition devices; the 25G Echotip Ultra Fine Needle Aspiration (FNA) device and the 20G Echotip ProCore Fine Needle Biopsy (FNB) device.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Masses, Lymph Nodes
CountriesAustralia, Belgium, France, Israel, Italy, Japan, Netherlands, Spain, Sweden, United States
CollaboratorsCook Ireland, Ltd.
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartFeb 2015
Primary CompletionJun 2017
TodayJul 2026
First PostedJun 18, 2014
Enrollment StartFeb 1, 2015
Primary CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.0 years ago
Interventions
25G FNA needledevice
20G ProCore FNB needledevice